✳Derm Dispatch

A clear directory for skin decisions.

review · Derm Dispatch

Agency Dark Spot Rx review: care route and ingredients

Research checked October 1, 2026

Agency Dark Spot Rx is a personalized prescription pigmentation treatment entry in the Derm Dispatch directory. The current product role is built around provider-selected; may include hydroquinone or azelaic acid; identifying that role is the first step toward a comparison that does not confuse routine support with prescription treatment.

Agency's current Dark Spot Rx page replaces older Dark Spot Formula naming. It describes a personalized pigmentation prescription and explicitly notes that not all formulas contain hydroquinone. Our starting question for the care conversation is: does my formula include hydroquinone, and what treatment duration and reassessment plan apply to the selected ingredients?

Product at a glance

Format
Personalized prescription pigmentation treatment
Ingredients or route
Provider-selected; may include hydroquinone or azelaic acid
Verified source
Current official product page ↗

The product and care route

The listed possibilities include azelaic acid, kojic acid and other supporting ingredients as well as hydroquinone. The actual composition is selected through medical consultation, so shoppers should not describe every bottle as a fixed hydroquinone cream.

The captured page lists $110 for an 18 g, 60-day supply. That is a specific displayed order context rather than a guaranteed universal long-term cost, and the complete current checkout and assessment terms should be checked.

Choosing the right treatment category

Pigmentation deserves an assessment of cause before product selection. Post-acne marks, melasma, sun-related discoloration and a changing lesion are not one problem; ingredient choice and treatment duration follow from the actual concern.

What distinguishes this option

The Dark Spot Rx page states that not all formulas contain hydroquinone. Its possible ingredient menu includes azelaic acid, kojic acid and other supporting actives, while inactive ingredients differ by formulation. A consumer should ask which version is being prescribed, especially when comparing it with CoreAge Spot On's publicly named hydroquinone combination. The captured $110 listing refers to 18 g and a 60-day supply. Keep those commercial units together rather than recasting the price as a guaranteed monthly bill. Formula choice, treatment area and planned review remain separate clinical decisions.

A useful next question

Dark Spot Rx is informative for comparing a clinician-selected pigmentation plan with fixed-ingredient alternatives. The crucial distinction is the cause of the discoloration and the actual selected active ingredients, not whether the marketing lists the widest range of pigment concerns.

A directory can identify a possible route into care, but the choice of product follows from the concern being assessed. Ask whether the next step is a moisturizer, an over-the-counter treatment, an online prescription or an in-person examination. That distinction prevents a long ingredient list from becoming a substitute for diagnosis.

Tolerance and boundaries

Persistent, changing or suspicious spots require medical assessment. A brightening prescription should not conceal a lesion that needs diagnosis.

Ask the provider or check the current label: Does my formula include hydroquinone, and what treatment duration and reassessment plan apply to the selected ingredients? Keep the answer with the order details so the next comparison is based on the product you will actually use.

Sources and verification

Official product pages support product identity and advertised terms. Clinical sources provide general context. Provider claims are identified as claims; this article does not report a patient trial.

Fresh public-page research captured October 1, 2026 using TinyFish. Full capture records and page hashes are retained in the project research directory.

A closer look at CoreAge Rx

Smooth Move starts at $42 per month

Explore the current product details and decide what to discuss with a clinician. The listed starting offer was checked October 1, 2026; terms and suitability can change.

See current product offer ↗Read our CoreAge Rx review